Thomas Decker (T Decker)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Electronic Health Record

Metastatic Breast Cancer

Endoplasmic Reticulum

Top Venues

Breast cancer research and treatment

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

M Thill, M-O Zahn, A Welt, E Stickeler, A Nusch, T Fietz, J Rauh, N Wetzel, L Kruggel, M Jänicke, N Marschner, N Harbeck, A Wöckel, Thomas Decker, null null
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL. Breast cancer research and treatment (2023)
M Thill, M-O Zahn, A Welt, E Stickeler, A Nusch, T Fietz, J Rauh, N Wetzel, L Kruggel, M Jänicke, N Marschner, N Harbeck, A Wöckel, Thomas Decker, null null
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL. Breast cancer research and treatment 198 (3) (2023)
M Thill, M-O Zahn, A Welt, E Stickeler, A Nusch, T Fietz, J Rauh, N Wetzel, L Kruggel, M Jänicke, N Marschner, N Harbeck, A Wöckel, Thomas Decker, null null
Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL. Breast cancer research and treatment 198 (3) (2023)
Geoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen, Katarzyna J Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steven McCune, Anne C Armstrong, Catherine Shannon, Gianfilippo Bertelli, Ching-Wei Chang, Rupal Desai, Kushagra Gupta, Timothy R Wilson, Aulde Flechais, Aditya Bardia
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Thomas Decker, Norbert Marschner, Axel Muendlein, Anja Welt, Volker Hagen, Jaqueline Rauh, Helge Schröder, Peter Jaehnig, Karin Potthoff, Christian Lerchenmüller
VicTORia: a randomised phase II study to compare vinorelbine in combination with the mTOR inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced HER2-negative breast cancer. Breast cancer research and treatment 176 (3) (2019)